OriGene Technologies, Inc.
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right

Search Results

Your search returned 9 results.
Search:

SKU Category Vector Description Price Delivery
MC206824 Mouse cDNA pCMV6-Entry Cd8a (untagged) - Mouse CD8 antigen, alpha chain (cDNA clone MGC:41580 IMAGE:1247019), (10ug) BC030679 $300 Immediate
MG202198 Mouse ORF PS100010 Cd8a (GFP-tagged) - Mouse CD8 antigen, alpha chain (cDNA clone MGC:41580 IMAGE:1247019), (10ug) BC030679 $330 Immediate
MR202198 Mouse ORF PS100001 Cd8a (Myc-DDK-tagged) - Mouse CD8 antigen, alpha chain (cDNA clone MGC:41580 IMAGE:1247019), (10ug) BC030679 $300 Immediate
MR202198L1 Mouse ORF PS100064 Lenti ORF clone of Cd8a (Myc-DDK-tagged) - Mouse CD8 antigen, alpha chain (cDNA clone MGC:41580 IMAGE:1247019), (10ug) BC030679 $420 1-2 weeks
MR202198L2 Mouse ORF PS100071 Lenti ORF clone of Cd8a (mGFP-tagged) - Mouse CD8 antigen, alpha chain (cDNA clone MGC:41580 IMAGE:1247019), (10ug) BC030679 $490 1-2 weeks
TF517859 Mouse shRNA pRFP-C-RS Cd8a - Mouse, 4 unique 29mer shRNA constructs in retroviral RFP vector $650 7-9 Days
TG517859 Mouse shRNA pGFP-V-RS Cd8a - Mouse, 4 unique 29mer shRNA constructs in retroviral GFP vector $650 7-9 Days
TL517859 Mouse shRNA pGFP-C-shLenti Cd8a - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector $750 7-9 Days
TR517859 Mouse shRNA pRS Cd8a - Mouse, 4 unique 29mer shRNA constructs in retroviral untagged vector $650 7-9 Days
Inc 5000 Healthcare Company Copyright © 2014 OriGene Technologies, Inc. All Rights Reserved. Legal Notices.
9620 Medical Center Dr., Suite 200, Rockville, MD 20850 • 1.888.267.4436

Reproduction of any materials from this website is strictly forbidden without permission.

All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title